HLHRUXO |
Phase Ib/II, clinical trial using ruxolitinib for treatment of patients with newly diagnosed or relapsed/refractory hemophagocytic lymphohistiocytosis (HLH) |
HLHRUXO |
Phase Ib/II, clinical trial using ruxolitinib for treatment of patients with newly diagnosed or relapsed/refractory hemophagocytic lymphohistiocytosis (HLH) |
Site Selection |
Study Overview |
Thirteen centers were selected to participate.
|
Clinical Coordinating Center
|
Operations & Data Coordinating Center
|